Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.08 USD | -1.69% | -5.40% | +16.56% |
May. 22 | Halozyme Therapeutics Insider Sold Shares Worth $905,480, According to a Recent SEC Filing | MT |
May. 07 | Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed | MT |
- Stock Market
- Equities
- HALO Stock
- News Halozyme Therapeutics, Inc.